Recombinant COVID-19 Nucleocapsid Protein (Omicron, B.1.1.529)
Recombinant COVID-19 Nucleocapsid Protein (Omicron, B.1.1.529) is produced by our E.coli expression system and the target gene encoding Met1-Ala419 (P13L, E31del, R32del, S33del, R203K, G204R) is expressed with a 6His tag at the N-terminus. The mutations were identified in the COVID-19 variant (known as Omicron/B.1.1.529 lineage) which emerged in South Africa.
Product Specifications
Product Name Alternative
SARS-CoV-2 coronavirus NP Protein; SARS-CoV-2 np Protein; SARS-CoV-2 novel coronavirus Nucleoprotein Protein
Reactivity
COVID-19
Source
E.coli
Applications
E, WB, SDS-PAGE, MS
Purity
Greater than 95% as determined by reducing SDS-PAGE.
Form
Liquid in a 0.2 μm filtered solution of 20 mM Tris-HCl, 300 mM NaCI, 1 mM EDTA, pH8.0.
Storage Conditions
Store it at -20°C to -80°C for one year. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Quality Control
Endotoxin: Less than 0.1 ng/μg (1 IEU/μg) as determined by LAL test.
SwissProt (Human)
P0DTC9
Entrez GeneHuman
43740575
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GPS2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)